THE DEFENDER:French Researchers Identify ‘Improbably High Rate of Deaths’ in Newborns Who Received New RSV Shot
Independent French researchers discovered a significant increase in newborn deaths in France coinciding with the rollout of Beyfortus, a new respiratory syncytial virus shot for infants.
French researchers identified possible safety signals in babies coinciding with the rollout of Beyfortus, a recently approved monoclonal antibody treatment for respiratory syncytial virus (RSV) in newborns.
In interviews with The Defender, the researchers — French independent scientist and author Hélène Banoun, Ph.D., and French statistician Christine Mackoi — explained that data from France’s National Institute of Statistics and Economic Studies (INSEE) indicates an improbably high rate of deaths of babies between 2 and 6 days old in France during September and October 2023.
READ ON AT THE DEFENDER…
Popular Rationalism is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.